Akash Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.25 Cr
- Paid Up Capital ₹ 1.25 Cr
- Company Age 30 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.86 M
- Revenue Growth %
- Profit Growth -6.44%
- Ebitda 63.21%
- Net Worth -13.48%
- Total Assets -7.03%
About Akash Laboratories
Akash Laboratories Private Limited (ALPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 November 1994 and has a history of 30 years and two months. Its registered office is in Kanchipuram, Tamil Nadu, India.
The Corporate was formerly known as Akash Laboratories Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.25 Cr and a paid-up capital of Rs 1.25 Cr.
The company currently has active open charges totaling ₹3.86 M.
Manohar Krishnan and Meera Manohar serve as directors at the Company.
Company Details
-
Location
Kanchipuram, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51909TN1994PTC029304
-
Company No.
029304
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
22 Nov 1994
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Akash Laboratories?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manohar Krishnan
|
Director | 13-Dec-2007 | Current |
|
Meera Manohar
|
Director | 13-Dec-2007 | Current |
Financial Performance of Akash Laboratories.
Akash Laboratories Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a slight decrease in profitability, with a 6.44% decrease in profit. The company's net worth observed a substantial decline by a decrease of 13.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Akash Laboratories?
In 2023, Akash Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0.39 Cr
₹0
Charges Breakdown by Lending Institutions
- The Tamil Nadu Industrial Investment Corporation Ltd : 0.33 Cr
- The Lakshmi Vilas Bank Limited : 0.06 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Apr 2009 | The Lakshmi Vilas Bank Limited | ₹0.60 M | Open |
| 09 Jan 2004 | The Tamil Nadu Industrial Investment Corporation Ltd | ₹1.06 M | Open |
| 12 Apr 2001 | The Tamil Nadu Industrial Investment Corporation Ltd | ₹2.20 M | Open |
How Many Employees Work at Akash Laboratories?
Unlock and access historical data on people associated with Akash Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Akash Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Akash Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
